RMD
Resmed Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Market Cap: 27.1 Billion
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Website: https://www.resmed.com/
Shares Outstanding: 147 Million
Float: 0
Dividend: 1.8723998008510243 (0.01%)
Beta: 1.014127282140228
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Ethical Flags
Longest drawdown: 547 trading days
From: 2015-04-10 To: 2017-06-12
Lowest Point:
New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
via: Business Wire at 2019-06-10 05:00:00:000
170 million people in North and South America have sleep apnea, ResMed study finds Researchers urge more screenings and cloud-connected treatment devices to curb growing health crisis ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South Am… read more...
New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
via: Business Wire at 2019-06-10 05:00:00:000
170 million people in North and South America have sleep apnea, ResMed study finds Researchers urge more screenings and cloud-connected treatment devices to curb growing health crisis ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South Am… read more...
New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
via: Business Wire at 2019-06-10 05:00:00:000
170 million people in North and South America have sleep apnea, ResMed study finds Researchers urge more screenings and cloud-connected treatment devices to curb growing health crisis ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South Am… read more...
Dividend Challenger Highlights: Week Of June 9
via: SeekingAlpha at 2019-06-10 02:40:50:000
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...
Dividend Challenger Highlights: Week Of June 9
via: SeekingAlpha at 2019-06-10 02:40:50:000
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...
Dividend Challenger Highlights: Week Of June 9
via: SeekingAlpha at 2019-06-10 02:40:50:000
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2019-08-14 | 2019-09-19 | 2019-08-15 | 2019-07-25 | 0.39 | Increase | |||
| 2019-05-08 | 2019-06-13 | 2019-05-09 | 2019-05-02 | 0.37 | No Change QoQ | |||
| 2019-02-06 | 2019-03-14 | 2019-02-07 | 2019-01-24 | 0.37 | No Change QoQ | |||
| 2018-11-07 | 2018-12-13 | 2018-11-08 | 2018-10-25 | 0.37 | No Change QoQ | |||
| 2018-08-15 | 2018-09-20 | 2018-08-16 | 2018-08-02 | 0.37 | Increase | |||
| 2018-05-09 | 2018-06-14 | 2018-05-10 | 2018-04-26 | 0.35 | No Change QoQ | |||
| 2018-02-07 | 2018-03-15 | 2018-02-08 | 2018-01-22 | 0.35 | No Change QoQ | |||
| 2017-11-08 | 2017-12-14 | 2017-11-09 | 2017-10-26 | 0.35 | No Change QoQ | |||
| 2017-08-15 | 2017-09-21 | 2017-08-17 | 2017-08-01 | 0.35 | Increase | |||
| 2017-05-09 | 2017-06-15 | 2017-05-11 | 2017-04-27 | 0.33 | No Change QoQ | |||
| 2017-02-07 | 2017-03-16 | 2017-02-09 | 2017-01-23 | 0.33 | No Change QoQ | |||
| 2016-11-08 | 2016-12-15 | 2016-11-10 | 2016-10-25 | 0.33 | No Change QoQ | |||
| 2016-08-16 | 2016-09-22 | 2016-08-18 | 2016-07-28 | 0.33 | Increase | |||
| 2016-05-17 | 2016-06-16 | 2016-05-19 | 2016-04-26 | 0.3 | No Change QoQ | |||
| 2016-02-09 | 2016-03-17 | 2016-02-11 | 2016-01-21 | 0.3 | No Change QoQ | |||
| 2015-11-17 | 2015-12-17 | 2015-11-19 | 2015-10-22 | 0.3 | No Change QoQ | |||
| 2015-08-18 | 2015-09-17 | 2015-08-20 | 2015-07-30 | 0.3 | Increase | |||
| 2015-05-19 | 2015-06-18 | 2015-05-21 | 2015-04-23 | 0.28 | No Change QoQ | |||
| 2015-02-10 | 2015-03-19 | 2015-02-12 | 2015-01-22 | 0.28 | No Change QoQ | |||
| 2014-11-18 | 2014-12-18 | 2014-11-20 | 2014-10-23 | 0.28 | No Change QoQ | |||
| 2019-11-06 | 2019-12-12 | 2019-11-07 | 2019-10-24 | 0.39 | Cash | |||
| 2020-02-12 | 2020-03-19 | 2020-02-13 | 2020-01-30 | 0.39 | Cash | |||
| 2020-05-13 | 2020-06-18 | 2020-05-14 | 2020-04-30 | 0.39 | Cash | |||
| 2020-08-19 | 2020-09-24 | 2020-08-20 | 2020-08-05 | 0.39 | Cash | |||
| 2020-11-10 | 2020-12-17 | 2020-11-12 | 2020-10-29 | 0.39 | Cash | |||
| 2023-02-08 | 2023-03-16 | 2023-02-09 | 2023-01-26 | 0.44 | Cash | |||
| 2023-05-10 | 2023-06-15 | 2023-05-11 | 2023-04-27 | 0.44 | Cash | |||
| 2023-08-16 | 2023-09-21 | 2023-08-17 | 2023-08-03 | 0.48 | Cash | |||
| 2023-11-08 | 2023-12-14 | 2023-11-09 | 2023-10-26 | 0.48 | Cash | |||
| 2024-02-07 | 2024-03-14 | 2024-02-08 | 2024-01-24 | 0.48 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|